1. Home
  2. TRVI vs RITR Comparison

TRVI vs RITR Comparison

Compare TRVI & RITR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • RITR
  • Stock Information
  • Founded
  • TRVI 2011
  • RITR 2015
  • Country
  • TRVI United States
  • RITR Hong Kong
  • Employees
  • TRVI N/A
  • RITR N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • RITR
  • Sector
  • TRVI Health Care
  • RITR
  • Exchange
  • TRVI Nasdaq
  • RITR NYSE
  • Market Cap
  • TRVI 211.4M
  • RITR 249.8M
  • IPO Year
  • TRVI 2019
  • RITR 2024
  • Fundamental
  • Price
  • TRVI $2.75
  • RITR $4.00
  • Analyst Decision
  • TRVI Strong Buy
  • RITR
  • Analyst Count
  • TRVI 8
  • RITR 0
  • Target Price
  • TRVI $9.13
  • RITR N/A
  • AVG Volume (30 Days)
  • TRVI 659.5K
  • RITR 197.0K
  • Earning Date
  • TRVI 11-06-2024
  • RITR 11-26-2024
  • Dividend Yield
  • TRVI N/A
  • RITR N/A
  • EPS Growth
  • TRVI N/A
  • RITR N/A
  • EPS
  • TRVI N/A
  • RITR 0.04
  • Revenue
  • TRVI N/A
  • RITR $32,198,033.00
  • Revenue This Year
  • TRVI N/A
  • RITR N/A
  • Revenue Next Year
  • TRVI N/A
  • RITR N/A
  • P/E Ratio
  • TRVI N/A
  • RITR $95.05
  • Revenue Growth
  • TRVI N/A
  • RITR 74.80
  • 52 Week Low
  • TRVI $0.97
  • RITR $3.30
  • 52 Week High
  • TRVI $4.00
  • RITR $8.75
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 37.52
  • RITR N/A
  • Support Level
  • TRVI $2.80
  • RITR N/A
  • Resistance Level
  • TRVI $3.22
  • RITR N/A
  • Average True Range (ATR)
  • TRVI 0.20
  • RITR 0.00
  • MACD
  • TRVI -0.03
  • RITR 0.00
  • Stochastic Oscillator
  • TRVI 14.68
  • RITR 0.00

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About RITR REITAR LOGTECH HLDGS LTD

Reitar Logtech Holdings Ltd provide one-stop solutions for logistics property operations in property development and redevelopment projects. It consists of two segments: construction management and engineering design services; and asset management and professional consultancy services in Hong Kong. Key revenue is generated from construction management and engineering design services.

Share on Social Networks: